dc.contributor.author | Selçuk, I. | |
dc.contributor.author | Meydanlı, M. M. | |
dc.contributor.author | Yalçın, I. | |
dc.contributor.author | Güngördük, Kemal | |
dc.contributor.author | Akgol, S. | |
dc.contributor.author | Celik, H. | |
dc.contributor.author | Ayhan, A. | |
dc.date.accessioned | 2020-11-20T14:40:38Z | |
dc.date.available | 2020-11-20T14:40:38Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 1048-891X | |
dc.identifier.issn | 1525-1438 | |
dc.identifier.uri | https://doi.org/10.1136/ijgc-2019-ESGO.38 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12809/781 | |
dc.description | WOS: 000523502500039 | en_US |
dc.description.abstract | The aim of this study was to analyze the survival outcomes of stage IIIC ovarian high-grade serous carcinoma (HGSC) patients with both peritoneal and lymphatic dissemination (IP(+)/RP(+)) who had undergone maximal or optimal cytoreduction followed by intravenous carboplatin/paclitaxel chemotherapy to those women with stage IIIC ovarian HGSC who have only peritoneal involvement (IP(+)/RP(-)) treated similarly. | en_US |
dc.item-language.iso | eng | en_US |
dc.publisher | Bmj Publishing Group | en_US |
dc.item-rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Gynecologic Oncology | en_US |
dc.title | COMPARISON OF SURVIVAL OUTCOMES IN OPTIMALLY OR MAXIMALLY CYTOREDUCTED STAGE IIIC OVARIAN HIGH-GRADE SEROUS CARCINOMA: WOMEN WITH ONLY PERITONEAL TUMOR BURDEN VERSUS WOMEN WITH BOTH PERITONEAL AND LYMPHOGENOUS DISSEMINATION | en_US |
dc.item-type | conferenceObject | en_US |
dc.contributor.department | MÜ, Eğitim ve Araştırma Hastanesi | en_US |
dc.contributor.institutionauthor | Güngördük, Kemal | |
dc.identifier.volume | 29 | en_US |
dc.identifier.startpage | A36 | en_US |
dc.identifier.endpage | A36 | en_US |
dc.relation.journal | International Journal of Gynecological Cancer | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |